Hepatitis C virus genotype 1 infection: Prevalence of NS5A and NS5B resistance‐associated substitutions in naïve patients from Argentina

AP Martínez, G García, E Ridruejo… - Journal of medical …, 2019 - Wiley Online Library
Direct acting antiviral (DAA) therapy against hepatitis C virus (HCV) increases sustained
virologic response rates. Nevertheless, drug resistance has occasionally been associated …
被引用次数：12 相关文章
[PDF] google.com

[PDF][PDF] Hepatitis C virus genotype 1 infection: Prevalence of NS5A and NS5B resistance‐associated substitutions in naïve patients from Argentina

AP Martínez, G García, E Ridruejo… - Journal of medical …, 2019 - drive.google.com
Direct acting antiviral (DAA) therapy against hepatitis C virus (HCV) increases sustained
virologic response rates. Nevertheless, drug resistance has occasionally been associated …

Hepatitis C virus genotype 1 infection: Prevalence of NS5A and NS5B resistance-associated substitutions in naïve patients from Argentina

AP Martínez, G García, E Ridruejo… - 2019 - datosdeinvestigacion.conicet.gov.ar
Direct acting antiviral (DAA) therapy against hepatitis C virus (HCV) increases sustained
virologic response rates. Nevertheless, drug resistance has occasionally been associated …

Hepatitis C virus genotype 1 infection: prevalence of NS5A and NS5B resistance-associated substitutions in naïve patients from Argentina.

AP Martínez, G García, E Ridruejo… - Journal of Medical …, 2019 - cabdirect.org
Direct acting antiviral (DAA) therapy against hepatitis C virus (HCV) increases sustained
virologic response rates. Nevertheless, drug resistance has occasionally been associated …

Hepatitis C virus genotype 1 infection: Prevalence of NS5A and NS5B resistance-associated substitutions in naïve patients from Argentina

AP Martínez, G García, E Ridruejo… - Journal of medical …, 2019 - pubmed.ncbi.nlm.nih.gov
Direct acting antiviral (DAA) therapy against hepatitis C virus (HCV) increases sustained
virologic response rates. Nevertheless, drug resistance has occasionally been associated …

Hepatitis C virus genotype 1 infection: Prevalence of NS5A and NS5B resistance-associated substitutions in naïve patients from Argentina

AP Martínez, G García, E Ridruejo… - 2019 - notablesdelaciencia.conicet.gov.ar
Direct acting antiviral (DAA) therapy against hepatitis C virus (HCV) increases sustained
virologic response rates. Nevertheless, drug resistance has occasionally been associated …

Hepatitis C virus genotype 1 infection: prevalence of NS5A and NS5B resistance-associated substitutions in naïve patients from Argentina.

AP Martínez, G García, E Ridruejo, ACA Culasso… - 2019 - cabidigitallibrary.org
Direct acting antiviral (DAA) therapy against hepatitis C virus (HCV) increases sustained
virologic response rates. Nevertheless, drug resistance has occasionally been associated …

Hepatitis C virus genotype 1 infection: Prevalence of NS5A and NS5B resistance‐associated substitutions in naïve patients from Argentina

AP Martínez, G García, E Ridruejo, ACA Culasso… - 2019 - digital.csic.es
Direct acting antiviral (DAA) therapy against hepatitis C virus (HCV) increases sustained
virologic response rates. Nevertheless, drug resistance has occasionally been associated …

Hepatitis C virus genotype 1 infection: Prevalence of NS5A and NS5B resistance-associated substitutions in naïve patients from Argentina

AP Martínez, G García, E Ridruejo, ACA Culasso… - 2019 - ri.conicet.gov.ar
Direct acting antiviral (DAA) therapy against hepatitis C virus (HCV) increases sustained
virologic response rates. Nevertheless, drug resistance has occasionally been associated …

Hepatitis C virus genotype 1 infection: Prevalence of NS5A and NS5B resistance-associated substitutions in naïve patients from Argentina.

AP Martínez, G García, E Ridruejo… - Journal of Medical …, 2019 - europepmc.org
Direct acting antiviral (DAA) therapy against hepatitis C virus (HCV) increases sustained
virologic response rates. Nevertheless, drug resistance has occasionally been associated …